Indian government procures over 1 crore Covidshield vaccine doses for ₹200 apiece and 55 lakh Covaxin doses for ₹206

New Delhi, Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of ₹200 and ₹206 per dose, respectively.

"As many as 110 lakh (1.1 crore) doses of Covishield vaccine are being procured from the Serum Institute of India at a cost of ₹200 per dose, excluding taxes. A total of 55 lakh doses of Covaxin vaccine are being procured from Bharat Biotech," Union Health Secretary Rajesh Bhushan said during a press conference.2

The cost of 38.5 lakh doses of Covaxin is ₹295 per dose, excluding taxes. Bharat Biotech is providing 16.5 lakh doses of Covaxin free of cost to the Central government. Hence, the cost of Covaxin comes to ₹206 per dose," he added.

Vaccines have already reached some states. Till 4 p.m., about 54,72,000 doses were received by the states and Union Territories. By January 14, 100% doses will be received.

The much-awaited Covid-19 vaccination drive will kick-off on January 16. The Central government plans to vaccinate nearly 30 crore people in the first phase of the drive. Priority will be given to the healthcare and frontline workers who are estimated to be around three crore, followed by those above 50 years of age and the under-50 population with comorbidities numbering around 27 crore.

On January 3, two vaccines -- Bharat Biotech's Covaxin and Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India -- were approved for 'restricted emergency use'. Few more vaccines are in the pipeline and are conducting trials.


SEE ALSO:
How to backup and restore messages in Signal app
WhatsApp says your privacy won't be affected if you don't use these two optional features
India's top court puts three new farm laws on hold — forms a five-member panel to resolve the deadlock